The rate of arterial and venous thrombosis was significant in patients with myeloproliferative neoplasms, according to research published in Annals of Internal Medicine.
“Patients with myeloproliferative neoplasms have been reported to be at increased risk for thrombotic events, but no population-based study has estimated this excess risk compared with matched control participants,” Malin Hultcrantz, MD, PhD, from Karolinska University Hospital and Karolinska Institutet, Stockholm, and colleagues wrote.
No commercial support for this activity.
At Issue: Melanoma Resource Center
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
©2018 Healio All Rights Reserved.